相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Indoloquinolines as Scaffolds for Drug Discovery
J. Lavrado et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Quinoline-Based Antifungals
R. Musiol et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Privileged scaffolds for library design and drug discovery
Matthew E. Welsch et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
Synthesis, anti-inflammatory and anticancer activity evaluation of some novel acridine derivatives
Sham M. Sondhi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Quinolines and structurally related heterocycles as antimalarials
Kirandeep Kaur et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Complementary medicinal chemistry-driven strategies toward new antitrypanosomal and antileishmanial lead drug candidates
Andrea Cavalli et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2010)
Polyamines in Drug Discovery: From the Universal Template Approach to the Multitarget-Directed Ligand Design Strategy
Carlo Melchiorre et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Discovery of 1-(4-(4-Propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one as a Highly Potent, Selective Mammalian Target of Rapamycin (mTOR) Inhibitor for the Treatment of Cancer
Qingsong Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Trioxaferroquines as New Hybrid Antimalarial Drugs
Francois Bellot et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Parallel Synthesis, Evaluation, and Preliminary Structure-Activity Relationship of 2,5-Diamino-1,4-benzoquinones as a Novel Class of Bivalent Anti-Prion Compound
Salvatore Bongarzone et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Discovery of 4-(4-(2-((5-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)(propyl)amino)ethyl)piperazin-1-yl)quinolin-8-ol and Its Analogues as Highly Potent Dopamine D2/D3 Agonists and as Iron Chelator: In Vivo Activity Indicates Potential Application in Symptomatic and Neuroprotective Therapy for Parkinson's Disease
Balaram Ghosh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Novel Tacrine-8-Hydroxyquinoline Hybrids as Multifunctional Agents for the Treatment of Alzheimer's Disease, with Neuroprotective, Cholinergic, Antioxidant, and Copper-Complexing Properties
Maria Isabel Fernandez-Bachiller et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin
Steven D. Knight et al.
ACS MEDICINAL CHEMISTRY LETTERS (2010)
Synthesis of Monomeric and Dimeric Acridine Compounds as Potential Therapeutics in Alzheimer and Prion Diseases
Rene Csuk et al.
ARCHIV DER PHARMAZIE (2009)
Synthesis of 9-anilinoacridine triazines as new class of hybrid antimalarial agents
Ashok Kumar et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Privileged structure-guided synthesis of quinazoline derivatives as inhibitors of trypanothione reductase
Andrea Cavalli et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Recent developments in the design and synthesis of hybrid molecules based on aminoquinoline ring and their antiplasmodial evaluation
Vladimir V. Kouznetsov et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
Phase transfer catalyzed synthesis of bis-quinolines: Antileishmanial activity in experimental visceral leishmaniasis and in vitro antibacterial evaluation
Partha Palit et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
A Candidate Anti-Prion Disease Agent, 2,2′-Biquinoline, Decreases Expression of Prion Protein and mRNA in Prion-Infected Cells
Tomoko Fukuuchi et al.
JOURNAL OF HEALTH SCIENCE (2009)
Combining 4-Aminoquinoline- and Clotrimazole-Based Pharmacophores toward Innovative and Potent Hybrid Antimalarials
Sandra Gemma et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Neglected Tropical Diseases: Multi-Target-Directed Ligands in the Search for Novel Lead Candidates against Trypanosoma and Leishmania
Andrea Cavalli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Pyrano[3,2-c]quinoline-6-Chlorotacrine Hybrids as a Novel Family of Acetylcholinesterase- and β-Amyloid-Directed Anti-Alzheimer Compounds
Pelayo Camps et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial
John Collinge et al.
LANCET NEUROLOGY (2009)
Discovery of dual function acridones as a new antimalarial chemotype
Jane X. Kelly et al.
NATURE (2009)
Lessons from 60 years of pharmaceutical innovation
Bernard Munos
NATURE REVIEWS DRUG DISCOVERY (2009)
Clioquinol and other hydroxyquinoline derivatives inhibit Aβ(1-42) oligomer assembly
Harry LeVine et al.
NEUROSCIENCE LETTERS (2009)
Addition of PTK787/ZK 222584 can lower the dosage of amsacrine to achieve equal amounts of acute myeloid leukemia cell death
Alida C. Weidenaar et al.
ANTI-CANCER DRUGS (2008)
Antiprion activity of functionalized 9-aminoacridines related to quinacrine
Hanh Thuy Nguyen Thi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Synthesis of 2-[3-(7-Chloro-quinolin-4-ylamino)-alkyl]-1-(substituted phenyl)-2,3,4,9-tetrahydro-1H-β-carbolines as a new class of antimalarial agents
Leena Gupta et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Ferrocene conjugates of chloroquine and other antimalarials: the development of ferroquine, a new antimalarial
Daniel Dive et al.
CHEMMEDCHEM (2008)
Design, synthesis, and structure-activity relationship studies of 4-quinolinyl- and 9-acrydinylhydrazones as potent antimalarial agents
Caterina Fattorusso et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Multi-target-directed ligands to combat neurodegenerative diseases
Andrea Cavalli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Aβ
Paul A. Adlard et al.
NEURON (2008)
Selection of a trioxaquine as an antimalarial drug candidate
Frederic Cosledan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Privileged scaffolds targeting reverse-turn and helix recognition
Ye Che et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
Hemin interactions and alterations of the subcellular localization of prion protein
Kil S. Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Design, synthesis, and antimalarial activity of structural chimeras of thiosemicarbazone and ferroquine analogues
Christophe Biot et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Privileged structures: A useful concept for the rational design of new lead drug candidates
Carolina D. Duarte et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2007)
Synthesis and antileishmanial activity of 6-mono-substituted and 3,6-di-substituted acridines obtained by acylation of proflavine
Carole Di Giorgio et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2007)
Therapeutic approaches for prion and Alzheimer's diseases
Thomas Wisniewski et al.
FEBS JOURNAL (2007)
2-(4-chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[H]quinoline-4-carboxylic acid (PSI-697):: Identification of a clinical candidate from the quinoline salicylic acid series of P-selectin antagonists
Neelu Kaila et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
8-aminoquinolines: future role as antiprotozoal drugs
Babu L. Tekwani et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2006)
Drug discovery and development for neglected parasitic diseases
Adam R. Renslo et al.
NATURE CHEMICAL BIOLOGY (2006)
Design and synthesis of substituted quinolines as novel and selective melanin concentrating hormone antagonists as anti-obesity agents
Namal C. Warshakoon et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Synthesis and SAR study of acridine, 2-methylquinoline and 2-phenylquinazoline analogues as anti-prion agents
H. Cope et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2006)
Structure-activity relationship study of 9-aminoacridine compounds in scrapie-infected neuroblastoma cells
Barnaby C. H. May et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Similar structure-activity relationships of quinoline derivatives for antiprion and antimalarial effects
Ralf Klingenstein et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Tricyclic antidepressants, quinacrine and a novel, synthetic chimera thereof clear prions by destabilizing detergent-resistant membrane compartments
Ralf Klingenstein et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Are target-family-privileged substructures truly privileged?
DM Schnur et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
A medicinal chemistry perspective on 4-aminoquinoline antimalarial drugs
Paul M. O'Neill et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2006)
Recent advances in the solid-phase combinatorial synthetic strategies for the benzodiazepine based privileged structures
A Kamal et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2006)
Sol-gel chemistry in medicinal science
T Coradin et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Synthesis and antileishmanial activities of 4,5-di-substituted acridines as compared to their 4-mono-substituted homologues
D Carole et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
Design, synthesis and anti-plasmodial evaluation in vitro of new 4-aminoquinoline isatin derivatives
I Chiyanzu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
Insights into the mechanism of action of ferroquine. Relationship between physicochemical properties and antiplasmodial activity
Christophe Biot et al.
MOLECULAR PHARMACEUTICS (2005)
Mefloquine increases the risk of serious psychiatric events during travel abroad: A nationwide case-control study in the Netherlands
MA van Riemsdijk et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Piperaquine - A resurgent antimalarial drug
TME Davis et al.
DRUGS (2005)
Molecular recognition: the fragment approach in lead generation
D Fattori
DRUG DISCOVERY TODAY (2004)
Recognition of privileged structures by G-protein coupled receptors
K Bondensgaard et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Quinoline derivatives are therapeutic candidates for transmissible spongiform encephalopathies
I Murakami-Kubo et al.
JOURNAL OF VIROLOGY (2004)
From magic bullets to designed multiple ligands
R Morphy et al.
DRUG DISCOVERY TODAY (2004)
Privileged structures: Applications in drug discovery
RW DeSimone et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2004)
A specific mechanism of nonspecific inhibition
SL McGovern et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Medicinal chemistry of target family-directed masterkeys
G Müller
DRUG DISCOVERY TODAY (2003)
1,4-dihydropyridines as calcium channel ligands and privileged structures
DJ Triggle
CELLULAR AND MOLECULAR NEUROBIOLOGY (2003)
Hit and lead generation:: Beyond high-throughput screening
KH Bleicher et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Potent inhibition of scrapie prion replication in cultured cells by bis-acridines
BCH May et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The combinatorial synthesis of bicyclic privileged structures or privileged substructures
DA Horton et al.
CHEMICAL REVIEWS (2003)
Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting A beta amyloid deposition and toxicity in Alzheimer disease - A pilot phase 2 clinical trial
CW Ritchie et al.
ARCHIVES OF NEUROLOGY (2003)
In vitro activities of 7-substituted 9-chloro and 9-amino-2-methoxyacridines and their bis- and tetra-acridine complexes against Leishmania infantum
C Di Giorgio et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Antiprotozoal and cytotoxicity evaluation of sulfonamide and urea analogues of quinacrine
K Chibale et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease
C Korth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Treatment with a copper-zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice
RA Cherny et al.
NEURON (2001)
Antiplasmodial activity and cytotoxicity of bis-, tris-, and tetraquinolines with linear or cyclic amino linkers
S Girault et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Potent and specific inhibitors of trypanothione reductase from Trypanosoma cruzi:: Bis(2-aminodiphenylsulfides) for fluorescent labeling studies
S Girault et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2001)
Acridine - a neglected antibacterial chromophore
M Wainwright
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Antimalarial, antitrypanosomal, and antileishmanial activities and cytotoxicity of bis(9-amino-6-chloro-2-methoxyacridines):: Influence of the linker
S Girault et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation
K Doh-Ura et al.
JOURNAL OF VIROLOGY (2000)
分享论文
